Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels (Last Update Submitted that Met QC Criteria and No FEAR Act Data) as well as revision to v3.4.0. These changes replace the previous terms (Last Update Submitted that met QC Criteria, No FEAR Act data, and v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-23T21:08:11.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was applied, replacing the previous v3.3.3. The update appears to be a metadata/version bump with no visible changes to the study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-01-17T00:32:17.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Added a Locations section and Maryland as a location. Updated from revision v3.3.2 to v3.3.3, and removed the Maryland Locations entry and the HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-12-19T13:36:32.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    Revision changed from v3.3.1 to v3.3.2, which appears to be an administrative metadata update and does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:00:05.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision history updated from v3.2.0 to v3.3.1; no substantive changes to the study details observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-21T02:13:38.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page removed the funding-status notice about potential delays due to government funding, removing a site-wide operational alert. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-13T22:44:06.000Z thumbnail image

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.